LBA-2: A New Cause of Hereditary and Acquired Erythrocytosis
At ASH 2024, François Girdon and Betty Gardie presented a Late Breaking Abstract on a new cause of erythrocytosis. The study aimed to investigate unexplained cases of hereditary and acquired erythrocytosis with normal erythropoietin (EPO) levels. The team identified a hepatic-like variant of EPO with enhanced activity, resembling fetal liver-derived EPO, as the driver of red blood cell overproduction. These findings suggest a need for qualitative EPO analysis in clinical practice to improve the diagnosis of idiopathic erythrocytosis.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in